Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938
Drug Test
  • April 11, 2025

Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS

This study is related to the development of a microextraction method for the determination of 56 psychoactive substances in oral…
fda-announces-plan-to-phase-out-animal-testing-requirement-for-monoclonal-antibodies-and-other-drugs Drug Test
  • April 10, 2025

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
other-|-cancer-accelerated-approvals Drug Test
  • April 10, 2025

Other | Cancer Accelerated Approvals

This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been granted for supportive care products…
fda-listing-of-authorized-generics Drug Test
  • April 9, 2025

FDA Listing of Authorized Generics

FDA Listing of Authorized Generics
fda-approves-nivolumab-with-ipilimumab-for-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer Drug Test
  • April 8, 2025

FDA approves nivolumab with ipilimumab for unresectable or metastatic MSI-H or dMMR colorectal cancer

On April 8, 2025, the FDA approved nivolumab (Opdivo, Bristol Myers Squibb Company) with ipilimumab (Yervoy, Bristol Myers Squibb Company)…
golden-state-medical-supply,-inc.-issues-a-voluntary-nationwide-recall-of-atenolol-25-mg-tablets-and-clopidogrel-75-mg-tablets-due-to-a-label-mix-up Drug Test
  • April 8, 2025

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up

Golden State Medical Supply, Incorporated (GSMS, Inc.) – Camarillo, CA has initiated a voluntary recall of the products listed in…
patient-focused-drug-development Drug Test
  • April 8, 2025

Patient-Focused Drug Development

The OCE PFDD program fosters collaboration between FDA centers and external stakeholders involved in patient outcomes research in cancer populations.
wwwthesafepills.org-–-702942-–-03/27/2025 Drug Test
  • April 8, 2025

www.thesafepills.org – 702942 – 03/27/2025

Unapproved New Drugs/Misbranded
Drug Test
  • April 8, 2025

Evaluating the Early Operational Performance of the Endocrine Module in the Athlete Biological Passport

The International Testing Agency, in collaboration with various Anti-Doping Organisations and the Paris WADA-accredited laboratory, led the Endocrine Module’s implementation…
ozempen.com-–-684435-–-06/24/2024 Drug Test
  • April 7, 2025

Ozempen.com – 684435 – 06/24/2024

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet